| Authors: |
Turner N; Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom., Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Aftimos P; Institut Jules Bordet-Université Libre de Bruxelles, Brussels, Belgium., van den Tweel E; Byondis B.V., Nijmegen, the Netherlands., Oesterholt M; Byondis B.V., Nijmegen, the Netherlands., Koper N; Byondis B.V., Nijmegen, the Netherlands., Colleoni M; Division of Medical Senology, European Institute of Oncology, Milan, Italy., Kaczmarek E; Medical Oncology Department, Centre Oscar Lambret, Lille, France., Punie K; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Song X; Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, ON, Canada., Armstrong A; Medical Oncology, The Christie NHS Foundation Trust and the University of Manchester, Manchester, United Kingdom., Bianchi G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stradella A; Department of Medical Oncology, Institut Català d'Oncologia-L'Hospitalet IDIBELL, Barcelona, Spain., Ladoire S; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Quenel-Tueux N; Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Tan TJ; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Escrivá-de-Romaní S; Medical Oncology Department, Vall d'Hebron University Hospital, and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., O'Shaughnessy J; Medical Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX. |
